Contrast-enhanced mammography: a systematic review and meta-analysis of diagnostic performance

A Cozzi, V Magni, M Zanardo, S Schiaffino… - Radiology, 2022 - pubs.rsna.org
Background Contrast-enhanced mammography (CEM) is a promising technique for breast
cancer detection, but conflicting results have been reported in previous meta-analyses …

Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR

DL Monticciolo, MS Newell, L Moy, CS Lee… - Journal of the American …, 2023 - Elsevier
Early detection decreases breast cancer death. The ACR recommends annual screening
beginning at age 40 for women of average risk and earlier and/or more intensive screening …

State-of-the-art for contrast-enhanced mammography

MF Covington, S Salmon, BD Weaver… - British Journal of …, 2024 - academic.oup.com
Contrast-enhanced mammography (CEM) is an emerging breast imaging technology with
promise for breast cancer screening, diagnosis, and procedural guidance. However, best …

Radiation dose of contrast-enhanced mammography: a two-center prospective comparison

G Gennaro, A Cozzi, S Schiaffino, F Sardanelli… - Cancers, 2022 - mdpi.com
Simple Summary Contrast-enhanced mammography (CEM) is a dual-energy technique
where low-and high-energy images are acquired for each mammographic view after …

Intra-and peritumoral radiomics of contrast-enhanced mammography predicts axillary lymph node metastasis in patients with breast cancer: a multicenter study

Z Wang, H Zhang, F Lin, R Zhang, H Ma, Y Shi… - Academic …, 2023 - Elsevier
Rationale and Objectives This multicenter study aimed to explore the feasibility of radiomics
based on intra-and peritumoral regions on preoperative breast cancer contrast-enhanced …

Contrast-enhanced mammography: a guide to setting up a new clinical program

G Kim, B Patel, TS Mehta, L Du… - Journal of Breast …, 2021 - academic.oup.com
Contrast-enhanced mammography (CEM) is gaining rapid traction following the US Food
and Drug Administration approval for diagnostic indications. Contrast-enhanced …

[HTML][HTML] BIRADS 4–Is it possible to downgrade lesions that do not enhance on recombinant contrast-enhanced mammography images?

A Grażyńska, A Niewiadomska, AJ Owczarek… - European Journal of …, 2023 - Elsevier
Purpose Analysis of the morphology of lesions classified into the BI-RADS 4 category and
assessment of the possibility of downgrade the BI-RADS category in those that did not show …

Quantitative analysis of contrast-enhanced mammography for risk stratification of benign versus malignant disease and molecular subtype

N Cain, G Rahbar, E Park, M Tang… - Journal of Breast …, 2022 - academic.oup.com
Objective To assess quantitative enhancement of benign, high-risk, and malignant lesions
and differences in molecular subtype and grade of malignant lesions on contrast-enhanced …

Contrast-enhanced Mammography versus MR Imaging of the Breast

RM Mann, V Longo - Radiologic Clinics, 2024 - radiologic.theclinics.com
Breast cancer is the most frequently diagnosed cancer in women, with approximately 1 in 3
malignancies being of breast origin, representing the leading cause of cancer death among …

The usefulness of spectral mammography in surgical planning of breast cancer treatment—Analysis of 999 patients with primary operable breast cancer

A Lorek, K Steinhof-Radwańska… - Current …, 2021 - mdpi.com
Contrast-enhanced spectral mammography (CESM) is a promising, digital breast imaging
method for planning surgeries. The study aimed at comparing digital mammography (MG) …